Sarepta Therapeutics, Inc. (LON:0L35)
London
· Delayed Price · Currency is GBP · Price in USD 38.38
+1.19 (3.19%)
At close: May 20, 2025
Sarepta Therapeutics Market Cap
Sarepta Therapeutics has a market cap or net worth of 2.84 billion as of May 23, 2025. Its market cap has decreased by -72.31% in one year.
Market Cap
2.84B
Enterprise Value
3.46B
Revenue
1.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
38.38
Market Cap Chart
Since June 4, 1997, Sarepta Therapeutics's market cap has increased from 43.06M to 2.84B, an increase of 6,493.21%. That is a compound annual growth rate of 16.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.83B |
| GSK plc | 57.45B |
| Haleon | 36.84B |
| Smith & Nephew | 9.51B |
| ConvaTec Group | 5.62B |
| Hikma Pharmaceuticals | 4.56B |
| HUTCHMED (China) | 1.76B |
| Genus | 1.38B |